Conviction
1 → 3
Conviction●●●○○3 of 5
Research target$350.12Snapshot target
Thesis statusINTACTLast reviewed 7/8/26
Market cap$23.53BSnapshot value
Research history
See all LH changes ↗What changed
Target
— → $350.12
Thesis status
NEEDS_MORE_DATA → INTACT
Last reviewed
Not reviewed → 7/8/26
Target
$350 → $350.12
Target
— → $350
Diagnostics network + specialty testing. Labcorp is the largest clinical lab network in the US. Drug development services (CRO-adjacent) add diversification.
Specialty testing growth (oncology, neurology); drug development services (Fortrea spin-off complete — now pure-play lab + CRO-adjacent); consumer testing.
Same as DGX: reimbursement pressure, labor inflation, PAMA risk. Fortrea spin-off removed the pure CRO exposure.
needs X/Reddit sentiment sweep
Snapshot · 7/8/26🟢 Lean-Bull · ins-$2.2M · 13F 14+/11- · short↓0.29
Snapshot · 7/8/26